Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways

被引：0
|
作者：
Fei Wang
Chong Yuan
Bo Liu
Yan-Fang Yang
He-Zhen Wu
机构：
[1] Hubei University of Chinese Medicine,Faculty of Pharmacy
[2] Key Laboratory of Traditional Chinese Medicine Resources and Chemistry of Hubei Province,undefined
来源：
Journal of Translational Medicine | / 20卷
关键词：
Syringin; (Rupr. & Maxim.) Harms; Breast cancer; Hub genes; Bioinformatics; Mechanism of action;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types
    Cijo George Vazhappilly
    Ekram Saleh
    Wafaa Ramadan
    Varsha Menon
    Aya Mudhafar Al-Azawi
    Hamadeh Tarazi
    Hajjaj Abdu-Allah
    Abdel-Nasser El-Shorbagi
    Raafat El-Awady
    Investigational New Drugs, 2019, 37 : 252 - 261
  • [42] Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types
    Vazhappilly, Cijo George
    Saleh, Ekram
    Ramadan, Wafaa
    Menon, Varsha
    Al-Azawi, Aya Mudhafar
    Tarazi, Hamadeh
    Abdu-Allah, Hajjaj
    El-Shorbagi, Abdel-Nasser
    El-Awady, Raafat
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 252 - 261
  • [43] Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway
    Wu, Linfeng
    Zhu, Kunyao
    Sun, Yan
    Li, Tinghao
    Zhu, Junlong
    Tong, Hang
    Zhang, Xiaoyu
    Chen, Junrui
    Yin, Hubin
    He, Weiyang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [44] Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis and autophagy via blocking Ras-Raf and PI3K-Akt signaling pathways
    Liu, Bo
    Wu, Jin-ming
    Li, Jing
    Liu, Jun-jie
    Li, Wen-wen
    Li, Chun-yang
    Xu, Huai-long
    Bao, Jin-ku
    BIOCHIMIE, 2010, 92 (12) : 1934 - 1938
  • [45] Novel STAT3 Inhibitor Exerts Anti-breast Cancer Effects Both in vitro and in vivo
    Liu, Zhe
    Sun, Yiming
    Yu, Meiling
    Huang, Yingying
    Ma, Liang
    Kong, Lingti
    LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (12) : 2070 - 2079
  • [46] MicroRNA-203a inhibits breast cancer progression through the PI3K/Akt and Wnt pathways
    Maryam Entezari
    Bahram M. Soltani
    Majid Sadeghizadeh
    Scientific Reports, 14
  • [47] MicroRNA-203a inhibits breast cancer progression through the PI3K/Akt and Wnt pathways
    Entezari, Maryam
    Soltani, Bahram M.
    Sadeghizadeh, Majid
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [48] CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways
    Bocca, C.
    Bozzo, F.
    Cannito, S.
    Colombatto, S.
    Miglietta, A.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 183 (01) : 187 - 193
  • [49] Uncovering of NRAGE/JNK and PI3K/AKT pathways through serial WGS of patients with breast cancer
    Lee, In Hee
    Lee, Soo Jung
    Kang, Byeongju
    Lee, Jeeyeon
    Kang, Jieun
    Kim, Eun Ae
    Jeong, Seolhwa
    Chae, Yee Soo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
    Lee, S-G
    Su, Z-Z
    Emdad, L.
    Sarkar, D.
    Franke, T. F.
    Fisher, P. B.
    ONCOGENE, 2008, 27 (08) : 1114 - 1121
12345